Works matching DE "EPIDERMAL growth factor receptors"


Results: 5000
    1
    2
    3
    4
    5
    6

    Analytical and Clinical Validation of the Oncomine Dx Target Test to Assess HER2 Mutation Status in Tumor Tissue Samples From Patients With Non-Small Cell Lung Cancer Treated With Trastuzumab Deruxtecan in the DESTINY-Lung01 and DESTINY-Lung02 Studies.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2025, v. 149, n. 6, p. 542, doi. 10.5858/arpa.2024-0014-OA
    By:
    • Zhenhao Qi;
    • Ha, Thomas;
    • Wenqin Feng;
    • Karnoub, Maha;
    • Pereira, Kaline;
    • Ryota Shiga;
    • Smit, Egbert F.;
    • Yasushi Goto;
    • De Langen, Adrianus Johannes;
    • Koichi Goto;
    • Velasco Roth, Anne Marie;
    • Khambata-Ford, Shirin
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf048
    By:
    • Ueno, Naoto T;
    • Cottone, Francesco;
    • Dunton, Kyle;
    • Jacot, William;
    • Yamashita, Toshinari;
    • Sohn, Joohyuk;
    • Tokunaga, Eriko;
    • Prat, Aleix;
    • Tsurutani, Junji;
    • Park, Yeon Hee;
    • Rugo, Hope S;
    • Xu, Binghe;
    • Cardoso, Fatima;
    • Mitri, Zahi;
    • Mahtani, Reshma;
    • Aguilar, Cecilia Orbegoso;
    • Xiao, Feng;
    • Harbeck, Nadia;
    • Cameron, David A;
    • Modi, Shanu
    Publication type:
    Article
    15
    16
    17

    Exploring the anticancer potential of Jerantinine A from Tabernaemontana coronaria against prostate, breast, and ovarian cancers: a computational approach.

    Published in:
    Journal of Complementary & Integrative Medicine, 2025, v. 22, n. 2, p. 363, doi. 10.1515/jcim-2024-0443
    By:
    • Kannappan, Poornima;
    • Kaniyur Chandrasekaran, Meenakshi;
    • Vani Raju, Manikandan;
    • Gopalakrishnan, Shankari;
    • Dhamodharan, Prabhu;
    • Muthaiyan Ahalliya, Rathi;
    • Palanisamy, Chella Perumal;
    • Raju, Balaji;
    • Velliyur Kanniappan, Gopalakrishnan
    Publication type:
    Article
    18
    19
    20
    21
    22

    Cardio–Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity.

    Published in:
    Antioxidants, 2025, v. 14, n. 5, p. 612, doi. 10.3390/antiox14050612
    By:
    • Quagliariello, Vincenzo;
    • Di Mauro, Annabella;
    • Ferrara, Gerardo;
    • Bruzzese, Francesca;
    • Palma, Giuseppe;
    • Luciano, Antonio;
    • Canale, Maria Laura;
    • Bisceglia, Irma;
    • Iovine, Martina;
    • Cadeddu Dessalvi, Christian;
    • Maurea, Carlo;
    • Barbato, Matteo;
    • Inno, Alessandro;
    • Berretta, Massimiliano;
    • Paccone, Andrea;
    • Mauriello, Alfredo;
    • Fonderico, Celeste;
    • Maratea, Anna Chiara;
    • Maurea, Nicola
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Efficient Design of Affilin ® Protein Binders for HER3.

    Published in:
    International Journal of Molecular Sciences, 2025, v. 26, n. 10, p. 4683, doi. 10.3390/ijms26104683
    By:
    • Diaz-Rovira, Anna M.;
    • Lotze, Jonathan;
    • Hoffmann, Gregor;
    • Pallara, Chiara;
    • Molina, Alexis;
    • Coburger, Ina;
    • Gloser-Bräunig, Manja;
    • Meysing, Maren;
    • Zwarg, Madlen;
    • Díaz, Lucía;
    • Guallar, Victor;
    • Bosse-Doenecke, Eva;
    • Roda, Sergi
    Publication type:
    Article
    47
    48
    49
    50